Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

BACKGROUND: HPV is a major cancer-causing factor in both sexes in the cervix, vulva, vagina, anus, penis, oropharynx as well as the causal factor in other diseases such as genital warts and recurrent respiratory papillomatis. In the context of the arrival of a nonavalent HPV vaccine (6/11/16/18/31/3...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Infect Dis
Hlavní autoři: Boiron, L., Joura, E., Largeron, N., Prager, B., Uhart, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833954/
https://ncbi.nlm.nih.gov/pubmed/27084683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1483-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky